More articles from In vitro and In vivo Oncology

You have access
CUB domain containing protein 1 is a target for radioligand therapy in multiple bladder cancer subtypes, including Nectin-4 and TROP2 null disease
Shalini Chopra, James Wells, Jie Zhou, Jonathon Chou and Michael Evans

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2563;
You have access
Research of an extracellular matrix-targeting antibody carrier for molecular imaging of pancreatic ductal adenocarcinoma
Zhixin Hao, Wenjia Zhu, Na Niu, Mei Zhang, Lei You, Jie Ding, Taiping Zhang, Yupei Zhao and Li Huo

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2571;
You have access
Antibody radioconjugates in combination with CD47 Immunotherapy Improves Antitumor Efficacy in preclinical models of solid tumors
Jason Li, Megan McCloskey, Caroline Jennings, Sagarika Pachhal, Emily Greer, Amanda Chin, Eileen Geoghegan, Qing Liang, Jesse Hwang, Monideepa Roy, Mary Chen, Dale Ludwig, Helen Kotanides and Denis Beckford

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2574;
You have access
A CXCR4-Targeting Radiotheranostic Based on a Potent Novel Peptide Antagonist
Daniel Kwon, Ingrid Bloise, Zhengxing Zhang, Ruiyan Tan, Ryan Wilson, Nadine Colpo, Helen Merkens, Jutta Zeisler, Kuo-Shyan Lin and Francois Benard

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2566;
You have access
Theranostic role of 89Zr/177Lu-labeled aflibercept in breast cancer
Lei Kang, Qi Yang, Zhao Chen, Yongkang Qiu, Wenpeng Huang, Lele Song and YAN FAN

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2562;
You have access
FAP-targeted molecular radiotherapy synergizes with checkpoint inhibitor immunotherapy to attenuate tumor growth in a murine model of non-small cell lung cancer
Kathleen Capaccione, Mikhail Doubrovin, Brian Braumuller, Dev Leibowitz, Nikunj Bhatt, Andrei Molotkov, Fatemeh Momen-Heravi and Akiva Mintz

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2564;
You have access
Longitudinal multi-tracer PET/CT characterization of oncogene-driven hepatocellular carcinoma formation in two transgenic mouse models
Mari Teuter, Asha Balakrishnan, Daniel Ahrens, Tobias Ross, Michael Ott, Frank Bengel and Jens Bankstahl

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2577;

Main menu

User menu

Search

More articles from In vitro and In vivo Oncology

Pages